Intellectual Property India Publishes Patent Application for 'Clinical Analysis And Methods For Predicting The Risk Of Developing Clinically Significant Prostate Cancer' Filed by Nanostics Inc.

MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202527053978 A) filed by Nanostics Inc., Edmonton, Canada, on June 4, for 'clinical analysis and methods for predicting the risk of developing clinically significant prostate cancer.'

Inventor(s) include Lewis, John; and Paproski, Robert.

The application for the patent was published on June 27, under issue no. 26/2025.

According to the abstract released by the Intellectual Property India: "This invention relates to a method, a non-transitory computer readable medium and a system for predicting the risk of developing clinically significant prostate cancer. A plurality of patients are selected based on a set of pre-determined criteria and clinical data points are obtained from the patients. The collected data points are further processed, engineered or statistically converted and the model hyper parameters are optimized by grid searching. The processed data points and the optimized hyper parameters are fed into a prediction system that is trained to generate a risk score using the information provided. The risk or probability of developing clinically significant prostate cancer is predicted based on the risk score."

The patent application was internationally filed on Nov. 03, 2023, under International application No.PCT/CA2023/051470.

Disclaimer: Curated by HT Syndication.